reports
Nilsson Special Vehicles AB: 2 directors
Two Directors at Nilsson Special Vehicles AB sold/bought 938,640 shares at 6.340SEK. The significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
London Stock Exchange Group: 1 director
Two Directors at London Stock Exchange Group bought/sold 5,711,036 shares at between 8,769p and 9,060p. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...
Raffles Medical Group Ltd: 1 director
A director at Raffles Medical Group Ltd bought 1,000,000 shares at 1.010SGD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
BTS Group Holding PCL: 1 director
A director at BTS Group Holding PCL bought 5,000,000 shares at 6.200THB and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its...
Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ) (“Eterna” or the “Company”), a preclinical-stage biopharmaceutical company, committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announces the appointment of Mahendra Rao, PhD, to its scientific advisory board. “We’re honored to have Dr. Mahendra Rao join our Scientific Advisory Board,” said Sanjeev Luther, President and CEO of Eterna. “His deep scientific...
Form 8.3 - Lok’n Store Group PLC
Form 8.3 - Lok’n Store Group PLC 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form re...
CN is Presenting 2023 Safe Handling Award to 193 Rail Shippers
CN is Presenting 2023 Safe Handling Award to 193 Rail Shippers MONTREAL, May 08, 2024 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) today announced the winners of its Safe Handling Award for 2023. CN’s Safe Handling Award is presented to customers who load freight cars with dangerous goods and meet strict standards for the safe handling and shipment of regulated products. The winners must meet established criteria, according to the total number of shipments of dangerous goods for all facilities. The Safe Handling Award goes hand in hand with CN’s goal to become the safest railway in Nor...
Le CN décerne le Prix de manutention sécuritaire de 2023 à 193 expédit...
Le CN décerne le Prix de manutention sécuritaire de 2023 à 193 expéditeurs ferroviaires MONTRÉAL, 08 mai 2024 (GLOBE NEWSWIRE) -- Le CN (TSX : CNR) (NYSE : CNI) a annoncé aujourd’hui les lauréats de son Prix de manutention sécuritaire de 2023. Le Prix de manutention sécuritaire du CN est remis aux clients qui font le chargement des marchandises dangereuses dans les wagons en respectant les normes rigoureuses en matière de manutention et d’expédition sécuritaires de produits réglementés. Les gagnants doivent respecter les critères en vigueur, selon le nombre total d’envois de marchandises...
Form 8.3 - GCP Asset Backed Income Fund Limited
Form 8.3 - GCP Asset Backed Income Fund Limited 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securiti...
Form 8.3 - Balanced Commercial Property Trust Limited
Form 8.3 - Balanced Commercial Property Trust Limited 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant se...
LIXTE Biotechnology Co-Sponsoring International Scientific Conference ...
LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer” Recent Findings Relate to LIXTE’s Lead Clinical Compound, LB-100, to be Presented at Workshop on May 9 and 10 at Harvard’s Dana Farber Cancer Institute in Boston PASADENA, CA, May 08, 2024 (GLOBE NEWSWIRE) -- . (“LIXTE” or the “Company”) (and LIXTW), a clinical stage pharmaceutical company, today announced it is co-sponsoring an international scientific workshop on “Therapeutic Over-Activation in Cancer” at Harvard University’s Dana Farber Cancer Institute on May 9 and 10, 202...
PT Bank Mandiri (Persero): 2 directors
Two Directors at PT Bank Mandiri (Persero) bought 1,400,000 shares at between 6,200.000IDR and 6,334.615IDR. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...
AKR Corporindo Tbk PT: 1 director
A director at AKR Corporindo Tbk PT bought 16,497,400 shares at 1,653.425IDR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
ABG Sundal Collier Initiates Coverage of CoinShares International Limi...
ABG Sundal Collier Initiates Coverage of CoinShares International Limited 8th May 2024 | SAINT HELIER, Jersey | CoinShares International Limited (“CoinShares'' or “the Group”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF), the leading European investment company specialising in digital assets, is pleased to announce that ABG Sundal Collier has initiated coverage of the Company. Click the full report or the report. ABOUT COINSHARES CoinShares is the leading European investment company specialising in digital assets, that delivers a broad range of fina...
Afsøgning af muligheder angående en rettet kapitalforhøjelse til marke...
Afsøgning af muligheder angående en rettet kapitalforhøjelse til markedskurs i Pharma Equity Group A/S 8. maj 2024 Meddelelse nr. 16 Afsøgning af muligheder angående en rettet kapitalforhøjelse til markedskurs i Pharma Equity Group A/S I forlængelse af selskabsmeddelelse nr. 15 fra 8. maj 2024 angående indkaldelse til en ekstraordinær generalforsamling den 3. juni 2024 med henblik på at nedsætte selskabets kapital, har bestyrelsen i Pharma Equity Group A/S ("PEG") i dag truffet beslutning om at afsøge mulighederne for at styrke PEG's arbejdskapital ved en kapitalforhøjelse til markedspr...
Exploration of options regarding a directed capital increase at market...
Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S 8 May 2024Announcement No. 16 Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S In continuation of company announcement no. 15 of 8 May 2024 regarding notice of an extraordinary general meeting, to be held on 3 June 2024. with a view to reducing the company's capital, the Board of Directors of Pharma Equity Group A/S ("PEG") has today decided to explore the possibilities of strengthening PEG's working capital through a capital in...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.